Locations:
Search IconSearch
November 6, 2017/Digestive/Surgery

Do Patients Really Need a Permanent Colostomy After Surgery for Rectal Cancer?

The short answer from Chairman Conor Delaney, MD, PhD

15-DDI-2421-Delaney-650×450-CQD

Q: Do patients really need a permanent colostomy after surgery for rectal cancer?

A: That is a really interesting question! What we know from the literature is that the utilization of an abdominoperineal resection with an end colostomy for rectal cancer is extremely variable when one looks at different surgeons or different centers.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

What many of us who do a lot of rectal cancer surgery know from our practices is the same. We are sent patients with mid-rectal tumors who have been told they need a permanent end colostomy. We get sent patients with tumors that are not reconstructable who’ve been told they can have a coloanal anastomosis.

The single most important thing is that the patient has a high quality cancer operation. This means religiously following the principles of appropriate preoperative evaluation, appropriate and selective preoperative radiation or chemoradiation, and most importantly, perfect anatomical total mesorectal excision. In patients who need the anal muscle taken out, this encompasses an appropriately wide excision of the levator muscles with a cylindrical specimen, recently redescribed as an extralevator abdominoperineal resection, but actually what Sir Ernest Miles proposed and performed about 100 years ago.

In patients who can have a coloanal anastomosis, these same cancer principles are followed. But a huge amount of attention must be put into the technically perfect anastomosis ― with perfect blood supply measured by seeing pulsating bleeding from the marginal vessel ― and excellent reach of the bowel, so there is no tension on the anastomosis.

How we choose the patients who can have an anastomosis ultimately depends on patient and surgeon characteristics. If a patient is motivated to have a coloanal anastomosis, will put up with the low anterior resection syndrome and some seepage that they may have, then they are an appropriate patient. The patient needs to be able to function adequately and be mobile. They need adequate sphincters and the tumor needs to be in an appropriate location.

Advertisement

Having said all of that, most patients with low rectal cancer can undergo a coloanal anastomosis. For upper rectal cancers, we need a 5-cm margin with a perpendicular transection of the mesorectum. For tumors in the middle and lower thirds, this often means transecting the bowel at the ano-rectal ring. In somebody in whom I can achieve a 2-cm margin, this is the minimal margin that I will accept.

Some patients, however, will have a tumor that is below the ano-rectal ring. If I can get a 2-cm margin by coming down to the dentate line and doing an intersphincteric resection, then I will. For these patients, as long as it is not a poorly differentiated tumor and as long as we have discussed postoperative function with the patient, we can actually take a 1-cm margin and do a hand-sewn anastomosis having done an intersphincteric resection. Oncological data suggest that this is equivalent to an abdominoperineal resection in these very low tumors. Motivated patients with good sphincters can do well and enjoy the chance of avoiding a permanent ostomy.

At the end of the day, the most important thing is to make sure that your patient with a mid- or lower rectal cancer is evaluated by a multidisciplinary team who see a high volume of these patients and therefore understand the complexities of rectal cancer treatment, and individualize decision-making as is required.

Conor Delaney, MD, PhD
Chairman, Digestive Disease & Surgery Institute
Cleveland Clinic

Follow Dr. Delaney on Twitter @ConorDelaneyMD

Advertisement

Related Articles

Doctor talking with patient
Consider Risk Factors When Deciding Care Path for Postoperative Crohn’s Disease

Strong patient communication can help clinicians choose the best treatment option

Federico Aucejo, MD
February 7, 2024/Digestive/Transplant
New Research Indicates Liver Transplant, Resection as an Option for Patients with CRLM

ctDNA should be incorporated into care to help stratify risk pre-operatively and for post-operative surveillance

Impostor phenomenon
February 6, 2024/Digestive/Research
Recognizing the Impact of Impostor Phenomenon and Microaggressions in Gastroenterology

The importance of raising awareness and taking steps to mitigate these occurrences

Koji Hashimoto, MD, and team
February 2, 2024/Digestive/Research
Combined Cardiac Surgery and Liver Transplant Is a New Option for Highly Selected Patients

New research indicates feasibility and helps identify which patients could benefit

Ajita Prabhu, MD
January 29, 2024/Digestive/Case Study
Case Study: Repair Surgery for Patient with Hernia and Abdominal Damage

Treating a patient after a complicated hernia repair led to surgical complications and chronic pain

liver
December 8, 2023/Digestive/Research
MILU Improves Outcomes Among Critically Ill Patients with Advanced Liver Disease

Standardized and collaborative care improves liver transplantations

alcohol
November 17, 2023/Digestive/Research
Younger Patients with Alcohol-Associated Hepatitis Present to the ED More Often, Research Shows

Caregiver collaboration and patient education remain critical

Ad